Detalles de la búsqueda
1.
Clinical burden and healthcare resource utilization associated with managing transfusion-dependent ß-thalassemia in France.
Curr Med Res Opin
; : 1-11, 2024 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38873781
2.
Economic and clinical burden of managing transfusion-dependent ß-thalassemia in the United States.
J Med Econ
; 26(1): 924-932, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37432699
3.
Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States.
Adv Ther
; 40(8): 3543-3558, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37332020
4.
Switch rates and total cost associated with apremilast and biologics in biologic-naive patients with psoriatic arthritis.
J Comp Eff Res
; 10(12): 989-998, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34187202
5.
Switch Rates and Total Cost of Care Associated with Apremilast and Biologic Therapies in Biologic-Naive Patients with Plaque Psoriasis.
Clinicoecon Outcomes Res
; 12: 369-377, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32765022
6.
Correction to: Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States.
Adv Ther
; 40(11): 5130, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37695467
7.
Impact of Outpatient vs Inpatient ABSSSI Treatment on Outcomes: A Retrospective Observational Analysis of Medical Charts Across US Emergency Departments.
Open Forum Infect Dis
; 5(7): ofy109, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30581883
Resultados
1 -
7
de 7
1
Próxima >
>>